Therefore, the aim of this feasibility study was to examine the effect of supervised endurance and strength training on ventricular remodeling, selected plasma markers, and exercise tolerance in HER2-positive BC women undergoing trastuzumab therapy. The gene discussed is ERBB2; the disease is breast cancer.